Mallinckrodt

is a Missouri-based specialty biopharmaceutical company that develops and commercializes medicines for the treatment of autoimmune and rare diseases...
Read more
Mallinckrodt President & CEO: Mark Trudeau

President & CEO

Mark Trudeau

CEO Approval Rating

69/100

1867

PublicMerger Pending with Endo, Inc.OTCMKTSMNKKQ

2834 NAICS listing
Annual Revenue
$2B
Employees
2,700
Acquisitions
9
Investments
1

Mallinckrodt Competitors

1Endo
2JM
3Mylan
4Pfizer
5Purdue Pharma
6TEVA
7Allergan
8AstraZeneca
9Merck
10Abbott

Trending Companies